Merck & Co., Inc. (MRK) Form 8-K — Oct 13, 2026

$MRKForm 8-KItems 5.02, 9.01Filed Oct 13, 2026, 12:36 PM ET0000310158-26-000237Original filing

Merck & Co. announced the election of Paul J. Diaz to its Board of Directors, effective November 1, 2026, via 8-K Items 5.02 and 9.01. Diaz is managing partner at Cressey & Company, a health care-focused private investment firm, and previously served as CEO of Myriad Genetics and Kindred Healthcare.

Key figures

Effective date: 2026-11-01
Board size after addition: 14

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.